Inhibikase Therapeutics I...

1.90
-0.08 (-4.04%)
At close: Apr 17, 2025, 3:59 PM
1.90
0.14%
After-hours: Apr 17, 2025, 06:38 PM EDT

Inhibikase Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
56.49M 9.17M 7.19M 40.75M 13.95M 18.46K 379.56K 16.66K 12.04K
41.05M 4.09M 15.86M n/a n/a n/a n/a n/a n/a
n/a n/a -15.85M n/a n/a n/a n/a 87.1K n/a
47.1K n/a 15.85M n/a n/a 2.87K 1.59M n/a 82.76K
n/a n/a 39.88K 110.14K n/a n/a 472.94K 180.78K 66.88K
n/a n/a 1.12M 107K n/a n/a n/a n/a 0.00
907.78K 739.18K 163.45K 1.5M 54.84K 16.92K n/a n/a n/a
98.45M 14.21M 24.37M 42.47M 14.78M 35.38K 1.25M 198.07K 80.16K
101.44K 295.6K 565.17K n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
148.54K 295.6K 565.17K n/a n/a 2.87K 1.59M 87.1K 82.76K
98.6M 14.51M 24.94M 42.47M 14.78M 38.25K 2.85M 285.17K 162.93K
943.02K 646.77K 1.15M 1.09M 1.72M 1M 954.24K 353.52K 431.79K
n/a n/a n/a n/a 2.33M 1.43M 262.37K 5.64K n/a
110.52K 381.78K 145.84K 248.91K 42.53K 98.42K 233.73K 459.96K 328.94K
2.68M 635.45K 1.79M n/a n/a n/a n/a n/a n/a
3.73M 3.44M 3.7M 4.05M 4.72M 4.25M 3.62M 1.73M 1.51M
n/a n/a n/a n/a 276.46K 275.38K n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a 90.12K 205.45K 2.72M 276.46K 275.38K 1.45M n/a n/a
3.73M 3.53M 3.9M 4.05M 5M 4.53M 3.62M 1.73M 1.51M
110.52K 622K 351.29K 248.91K 319K 373.79K 233.73K 459.96K 328.94K
69.36K 6.19K 25.23K 25.16K 10.05K 8.18K 8.18K 8.92K 8.92K
-94.42M -66.9M -47.87M -29.82M -15.03M -12.18M -6.46M -4.31M -3.87M
-37.25K 877.00 104.72K -0.00 0.00 n/a n/a n/a n/a
94.87M 10.98M 21.04M 38.42M 9.78M -4.49M -777.97K -1.44M -1.35M
41.05M 4.09M 15.86K n/a n/a n/a n/a 87.1K n/a